Copertina

A New Series of Amino Alcohol Oxime Ethers as Activators of Human Brain Carbonic Anhydrases: Advances in Selective Activation of Human Carbonic Anhydrase VII

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Camilla Mangini, Riccardo Di Leo, Jacopo Castagnoli, Alessio Nocentini, Paola Gratteri, Sabrina Taliani, Claudiu T. Supuran, Armando Rossello, Doretta Cuffaro, Elisa Nuti
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	ChemMedChem
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Synthesis and Carbonic Anhydrase I, II, IX, and XII Inhibition Studies with a Series of Cyclic Sulfonyl Guanidines
di: Morteza Abdoli, et al.
Pubblicazione: (2024)

Tailored Tetrasubstituted Imidazole Carrying the Benzenesulfonamide Fragments as Selective Human Carbonic Anhydrase IX/XII Inhibitors
di: Ehab S. Taher, et al.
Pubblicazione: (2024)

Exploring Coumarin‐Triazole Derivatives as Selective Inhibitors of Carbonic Anhydrase IX and XII
di: Vadakattu Manasa, et al.
Pubblicazione: (2026)

Effective Anticancer Potential of a New Sulfonamide as a Carbonic Anhydrase IX Inhibitor Against Aggressive Tumors
di: Ismail Koyuncu, et al.
Pubblicazione: (2024)

Exploration of 3‐Substituted Benzofuran‐Tethered Sulfamoyl Triazoles as Carbonic Anhydrase Inhibitors: Design, Synthesis, and Biological Evaluation
di: Anuradha Singampalli, et al.
Pubblicazione: (2025)

Targeting Tumor‐Associated Carbonic Anhydrases in Photothermal Therapy
di: Sébastien Clément, et al.
Pubblicazione: (2025)

4‐(5‐Chloro‐3‐(3,4,5‐trimethoxybenzoyl)‐1 H ‐indol‐1‐yl)benzenesulfonamide: A Novel Polypharmacology Agent to Target Carbonic Anhydrase IX and XII With Improved Selectivity, Wnt/β‐Catenin Signaling Pathway, and P‐Glycoprotein
di: Michela Puxeddu, et al.
Pubblicazione: (2026)

Exploring the potency of diazo‐coumarin containing hybrid molecules: Selective inhibition of tumor‐associated carbonic anhydrase isoforms IX and XII
di: Gönül Yapar, et al.
Pubblicazione: (2024)

Flavonoid Oxime Carbamate Derivatives: Reversal of Multidrug Resistance in Cancer Cells
di: Filipa Barbosa, et al.
Pubblicazione: (2026)

Lasamide Containing Sulfonylpiperazines as Effective Agents for the Management of Glaucoma Associated Symptoms
di: Jaydeo T. Kilbile, et al.
Pubblicazione: (2024)

Nucleic Acid Materials‐Mediated Innate Immune Activation for Cancer Immunotherapy
di: Xinyu Xu, et al.
Pubblicazione: (2024)

Recent Development of Transition Metal Complexes as Chemotherapeutic Hypoxia Activated Prodrug (HAP)
di: K. Jagathesan, et al.
Pubblicazione: (2024)

A Nitroreductase‐Activatable Lapachol Against Bacillus subtilis Unveils Antimicrobial Specificity
di: Ivonne R. Lopez‐Miranda, et al.
Pubblicazione: (2026)

Recent Developments On Activatable Turn‐On Fluorogenic Donors of Hydrogen Sulfide (H2S)
di: Roopjyoti Misra, et al.
Pubblicazione: (2024)

Azologs of the Fatty Acid Mimetic Drug Cinalukast Enable Light‐Induced PPARα Activation
di: Minh Sai, et al.
Pubblicazione: (2024)

Green Light Activated Dual‐Action Pt(IV) Prodrug with Enhanced PDT Activity
di: Daniil Spector, et al.
Pubblicazione: (2025)

AMPK Activation by 2′‐Hydroxy‐2,4,5‐Trimethoxychalcone Derivatives in Podocyte Cells
di: Vu‐Duy Nguyen, et al.
Pubblicazione: (2025)

Carbon Dots as Bioactive Antifungal Nanomaterials
di: Elisa Sturabotti, et al.
Pubblicazione: (2024)

Investigation of Muscarinic Acetylcholine Receptor M3 Activation in Atomistic Detail: A Chemist's Viewpoint
di: Matthäus Drabek, et al.
Pubblicazione: (2024)

Machine Learning‐Driven Discovery of Structurally Related Natural Products as Activators of the Cardiac Calcium Pump SERCA2a
di: Carlos Cruz‐Cortés, et al.
Pubblicazione: (2025)

Development of a Tumor Microenvironment‐Responsive Co(III)‐Chrysin Prodrug: Synthesis, Activation Profiling, and In Vitro Antineoplastic Evaluation
di: Prakash Shukla, et al.
Pubblicazione: (2025)

Functionalized Cyclic Beta‐Amino Acid Derivatives With Antiviral Potential
di: Melinda Nonn, et al.
Pubblicazione: (2026)

Small‐Molecule Sarco/Endoplasmic Reticulum Ca 2+ ‐ATPase Activators Reverse Methylglyoxal‐Induced Inhibition through Nonantioxidant Mechanisms
di: Carlos Cruz‐Cortés, et al.
Pubblicazione: (2025)

Development of a Neopentyl 211At‐Labeled Activated Ester Providing In Vivo Stable 211At‐Labeled Antibodies for Targeted Alpha Therapy
di: Masatoshi Tada, et al.
Pubblicazione: (2024)

Advanced Hydrogels: Enhancing Tissue Bioengineering with RGD Peptides and Carbon Nanomaterials
di: Josué M. Galindo, et al.
Pubblicazione: (2024)

Compounds Consisting of Quinazoline, Ibuprofen, and Amino Acids with Cytotoxic and Anti‐Inflammatory Effects
di: Luis Roberto Garduño‐Villavicencio, et al.
Pubblicazione: (2024)

Targeting Inflammatory and Oncogenic Pathways: Cyclooxygenase‐2, Epidermal Growth Factor Receptor, and p38 Mitogen‐Activated Protein Kinase Inhibition by Pyrazolone Derivatives
di: Sevde Nur Biltekin Kaleli, et al.
Pubblicazione: (2026)

A ProTide of AZT Shows Activity Against Human Papillomaviruses
di: Tim Gniech, et al.
Pubblicazione: (2024)

Chemical and Chemoenzymatic Synthesis of Peptide and Protein Therapeutics Conjugated with Human N‐Glycans
di: Hirofumi Ochiai, et al.
Pubblicazione: (2024)

Enhancing Stability and Entrapment Efficiency of Liposome‐Coated Mesoporous Silica Nanocarriers Using Polyoxyethylene Alkyl Ether as a Polyethylene Glycol Anchoring Agent
di: Tien‐Dung Nguyen‐Dinh, et al.
Pubblicazione: (2025)

Development of Keap1‐Nrf2 Protein–Protein Interaction Inhibitor Activating Intracellular Nrf2 Based on the Naphthalene‐2‐acetamide Scaffold, and its Anti‐Inflammatory Effects
di: Daisuke Yasuda, et al.
Pubblicazione: (2025)

Front Cover: Development of a Tumor Microenvironment‐Responsive Co(III)‐Chrysin Prodrug: Synthesis, Activation Profiling, and In Vitro Antineoplastic Evaluation (ChemMedChem 20/2025)
di: Prakash Shukla, et al.
Pubblicazione: (2025)

Structural Impact of 4‐Hydroxynonenal Modification on Human Cytochrome CYP4F11
di: Olena Gnatyuk, et al.
Pubblicazione: (2026)

Tumor Microenvironment‐Responsive Multinucleated Nanocomplexes Loaded with Carbon Dots for Combined Photothermal/Chemodynamic Therapy of Breast Cancer
di: Zihan Zhu, et al.
Pubblicazione: (2025)

Targeting Ubiquitin‐Specific Protease 7 with Novel 5‐Amino‐Pyrazole Inhibitors: Design, Synthesis, and Biological Evaluation
di: Matteo Lusardi, et al.
Pubblicazione: (2025)

Front Cover: Carbon‐13 Hyperpolarization of α‐Ketocarboxylates with Parahydrogen in Reversible Exchange (ChemMedChem 5/2025)
di: Stephen J. McBride, et al.
Pubblicazione: (2025)

Small‐Molecule Allosteric Inhibitors of Human Aspartate Transcarbamoylase Suppress Proliferation of Bone Osteosarcoma Epithelial Cells
di: Chao Wang, et al.
Pubblicazione: (2024)

Exploring the Anticancer Properties and Mode of Action of Copper(II)‐Furan Acylhydrazone on Human Triple Negative Breast Cancer Cells
di: Lucía Santa Maria de la Parra, et al.
Pubblicazione: (2026)

Insight into Stabilization of G‐Quadruplex in c‐MYC Region with Phenanthroimidazoisoindol‐Acrylates and their Binding Behaviour towards Human Serum Albumin
di: Rekha Thakur, et al.
Pubblicazione: (2025)

Front Cover: r‐BRICS – A Revised BRICS Module That Breaks Ring Structures and Carbon Chains (ChemMedChem 4/2024)
di: Leili Zhang, et al.
Pubblicazione: (2024)